Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications

Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 6

Abstract

Curcumin, an aromatic phytoextract from the turmeric (Curcuma longa) rhizome, has been used for centuries for a variety of purposes, not the least of which is medicinal. A growing body of evidence suggests that curcumin has a broad range of potentially therapeutic pharmacological properties, including anti-inflammatory, anti-fibrotic, and anti-neoplastic effects, among others. Clinical applications of curcumin have been hampered by quality control concerns and limited oral bioavailability, although novel formulations appear to have largely overcome these issues. Recent in vitro and in vivo studies have found that curcumin's cytoprotective and other biological activities may play a role in an array of benign and malignant hepatobiliary conditions, including but not limited to non-alcoholic fatty liver disease, cholestatic liver disease (e.g. primary sclerosing cholangitis), and cholangiocarcinoma. Here we provide an overview of fundamental principles, recent discoveries, and potential clinical hepatobiliary applications of this pleiotropic phytocompound.

Authors and Affiliations

Robert W. Hu, Elizabeth J. Carey, Keith D. Lindor, James H. Tabibian

Keywords

Related Articles

Greater Celandine hepatotoxicity: a clinical review

Herbal hepatotoxicity is a rare and poorly described disease because reported cases are mostly scattered and lack an appropriate causality assessment. We now describe in detail the clinical picture of herbal hepatotoxic...

Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQO

Background and rationale. It is well established that chronic viral hepatitis (CVH) negatively affects patients . health-related quality of life (HRQOL). The aim of the present study was to assess the extent to which fat...

Occult hepatitis B in patients on hemodialysis: a review

The hepatitis B virus (HBV) is one of the most frequently transmitted agents in dialysis units. Occult hepatitis B is characterized by HBV infection without detectable surface antigen (HBsAg) in the patient’s serum, a po...

Akin criteria as a predictor of mortality in cirrhotic patients after spontaneous bacterial peritonitis

Background and aims. Spontaneous bacterial peritonitis (SBP) often triggers acute-on-chronic liver failure (ACLF). Acute kidney injury (AKI) is frequent and correlates with higher mortality in such cases. The aim of this...

High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation

Background. Liver re-transplantation (re-OLT) remains the only feasible option for patients with graft failure following liver transplantation. Sparse resources and a growing waitlist mandate that available grafts are a...

Download PDF file
  • EP ID EP228011
  • DOI 10.5604/01.3001.0010.5273
  • Views 121
  • Downloads 0

How To Cite

Robert W. Hu, Elizabeth J. Carey, Keith D. Lindor, James H. Tabibian (2017). Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications. Annals of Hepatology, 16(6), 835-841. https://europub.co.uk/articles/-A-228011